Blood Pressure Medications - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Blood Pressure Medications Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Blood Pressure Medications Market Restraints
Table 3. Blood Pressure Medications Market Trends
Table 4. Blood Pressure Medications Industry Policy
Table 5. Global Blood Pressure Medications Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Blood Pressure Medications Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Blood Pressure Medications Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Blood Pressure Medications Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Blood Pressure Medications Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Blood Pressure Medications Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Blood Pressure Medications Mergers & Acquisitions, Expansion Plans
Table 12. Global Blood Pressure Medications Manufacturers Product Type
Table 13. Head Office and Blood Pressure Medications Production Site of Key Manufacturer
Table 14. Blood Pressure Medications Capacity of Major Manufacturers and Future Plan
Table 15. China Blood Pressure Medications Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Blood Pressure Medications Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Blood Pressure Medications Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Blood Pressure Medications Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Blood Pressure Medications Production by Region, 2018-2023, (K Units)
Table 20. Global Blood Pressure Medications Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Blood Pressure Medications Upstream (Raw Materials)
Table 22. Global Blood Pressure Medications Typical Customers
Table 23. Blood Pressure Medications Typical Distributors
Table 24. By Type, Global Blood Pressure Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Blood Pressure Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Blood Pressure Medications Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Blood Pressure Medications Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Blood Pressure Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Blood Pressure Medications Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Blood Pressure Medications Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Blood Pressure Medications Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Blood Pressure Medications Models, Specifications, and Application
Table 36. Pfizer Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Pfizer Company Profile and Main Business
Table 38. Pfizer Recent Developments
Table 39. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 40. Novartis Blood Pressure Medications Models, Specifications, and Application
Table 41. Novartis Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Novartis Company Profile and Main Business
Table 43. Novartis Recent Developments
Table 44. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 45. AstraZeneca Blood Pressure Medications Models, Specifications, and Application
Table 46. AstraZeneca Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. AstraZeneca Company Profile and Main Business
Table 48. AstraZeneca Recent Developments
Table 49. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 50. Bayer Blood Pressure Medications Models, Specifications, and Application
Table 51. Bayer Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Bayer Company Profile and Main Business
Table 53. Bayer Recent Developments
Table 54. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 55. Sanofi Blood Pressure Medications Models, Specifications, and Application
Table 56. Sanofi Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Sanofi Company Profile and Main Business
Table 58. Sanofi Recent Developments
Table 59. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 60. Boehringer Ingelheim Blood Pressure Medications Models, Specifications, and Application
Table 61. Boehringer Ingelheim Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Boehringer Ingelheim Company Profile and Main Business
Table 63. Boehringer Ingelheim Recent Developments
Table 64. Merck Company Information, Head Office, Market Area, and Industry Position
Table 65. Merck Blood Pressure Medications Models, Specifications, and Application
Table 66. Merck Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Merck Company Profile and Main Business
Table 68. Merck Recent Developments
Table 69. Lupin Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 70. Lupin Pharmaceuticals Blood Pressure Medications Models, Specifications, and Application
Table 71. Lupin Pharmaceuticals Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Lupin Pharmaceuticals Company Profile and Main Business
Table 73. Lupin Pharmaceuticals Recent Developments
Table 74. Huahai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Huahai Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
Table 76. Huahai Pharmaceutical Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Huahai Pharmaceutical Company Profile and Main Business
Table 78. Huahai Pharmaceutical Recent Developments
Table 79. Jiangsu Jibeier Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 80. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
Table 81. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Jiangsu Jibeier Pharmaceutical Company Profile and Main Business
Table 83. Jiangsu Jibeier Pharmaceutical Recent Developments
Table 84. Tianjin Pharmaceutical Da Ren Tang Group Company Information, Head Office, Market Area, and Industry Position
Table 85. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Models, Specifications, and Application
Table 86. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Tianjin Pharmaceutical Da Ren Tang Group Company Profile and Main Business
Table 88. Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
Table 89. Chengdu Easton Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 90. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Models, Specifications, and Application
Table 91. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Chengdu Easton Biopharmaceuticals Company Profile and Main Business
Table 93. Chengdu Easton Biopharmaceuticals Recent Developments
Table 94. Qingdao Huanghai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 95. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
Table 96. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Qingdao Huanghai Pharmaceutical Company Profile and Main Business
Table 98. Qingdao Huanghai Pharmaceutical Recent Developments
Table 99. CR Double-Crane Company Information, Head Office, Market Area, and Industry Position
Table 100. CR Double-Crane Blood Pressure Medications Models, Specifications, and Application
Table 101. CR Double-Crane Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. CR Double-Crane Company Profile and Main Business
Table 103. CR Double-Crane Recent Developments
Table 104. Shanghai Shyndec Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 105. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
Table 106. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Shanghai Shyndec Pharmaceutical Company Profile and Main Business
Table 108. Shanghai Shyndec Pharmaceutical Recent Developments
Table 109. CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
Table 110. CSPC Pharmaceutical Group Blood Pressure Medications Models, Specifications, and Application
Table 111. CSPC Pharmaceutical Group Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. CSPC Pharmaceutical Group Company Profile and Main Business
Table 113. CSPC Pharmaceutical Group Recent Developments
Table 114. Jiangsu Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position
Table 115. Jiangsu Hengrui Medicine Blood Pressure Medications Models, Specifications, and Application
Table 116. Jiangsu Hengrui Medicine Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Jiangsu Hengrui Medicine Company Profile and Main Business
Table 118. Jiangsu Hengrui Medicine Recent Developments
List of Figures
Figure 1. Blood Pressure Medications Picture
Figure 2. Global Blood Pressure Medications Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Blood Pressure Medications Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Blood Pressure Medications Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Blood Pressure Medications Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Blood Pressure Medications Sales Quantity (K Units) & (2018-2029)
Figure 7. China Blood Pressure Medications Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Blood Pressure Medications Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Blood Pressure Medications Market Share of Global, 2018-2029
Figure 10. Global Blood Pressure Medications Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Blood Pressure Medications Key Participants, Market Share, 2022
Figure 12. Global Blood Pressure Medications Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Blood Pressure Medications Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Blood Pressure Medications Production Market Share & Forecast by Region, 2018-2029
Figure 15. Blood Pressure Medications Industry Chain
Figure 16. Blood Pressure Medications Procurement Model
Figure 17. Blood Pressure Medications Sales Model
Figure 18. Blood Pressure Medications Sales Channels, Direct Sales, and Distribution
Figure 19. Calcium Channel Blockers
Figure 20. ACE Inhibitors
Figure 21. Angiotensin II Receptor Blockers
Figure 22. Beta Blockers
Figure 23. Compound Drugs
Figure 24. Diuretics
Figure 25. Others
Figure 26. By Type, Global Blood Pressure Medications Consumption Value, 2018-2029, US$ Million
Figure 27. By Type, Global Blood Pressure Medications Consumption Value Market Share, 2018-2029
Figure 28. By Type, Global Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 29. By Type, Global Blood Pressure Medications Sales Quantity Market Share, 2018-2029
Figure 30. By Type, Global Blood Pressure Medications Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 31. Hospital
Figure 32. Clinic
Figure 33. Others
Figure 34. By Application, Global Blood Pressure Medications Consumption Value, 2018-2029, US$ Million
Figure 35. By Application, Global Blood Pressure Medications Consumption Value Market Share, 2018-2029
Figure 36. By Application, Global Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 37. By Application, Global Blood Pressure Medications Sales Quantity Market Share, 2018-2029
Figure 38. By Application, Global Blood Pressure Medications Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 39. By Region, Global Blood Pressure Medications Consumption Value Market Share, 2018-2029
Figure 40. By Region, Global Blood Pressure Medications Sales Quantity Market Share, 2018-2029
Figure 41. North America Blood Pressure Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Blood Pressure Medications Consumption Value Market Share, 2022
Figure 43. Europe Blood Pressure Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Blood Pressure Medications Consumption Value Market Share, 2022
Figure 45. Asia Pacific Blood Pressure Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Blood Pressure Medications Consumption Value Market Share, 2022
Figure 47. South America Blood Pressure Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Blood Pressure Medications Consumption Value Market Share, 2022
Figure 49. Middle East & Africa Blood Pressure Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, U.S. Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 53. Europe Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Europe Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Europe Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 56. China Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, China Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, China Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 59. Japan Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Japan Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Japan Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 62. South Korea Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, South Korea Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, South Korea Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 65. Southeast Asia Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Southeast Asia Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Southeast Asia Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 68. India Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, India Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, India Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 71. Middle East & Africa Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Figure 72. By Type, Middle East & Africa Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 73. By Application, Middle East & Africa Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
Figure 74. Research Methodology
Figure 75. Breakdown of Primary Interviews
Figure 76. Bottom-up and Top-down Approaches
Figure 77. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets